Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Prospective, Randomized, Controlled, Multi-Center Study to Establish the Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients Who Have Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement
SIMR (Sacramento/Valley Area): Please contact simr@sutterhealth.org about Study PARTNER 3 Low Risk TAVR
Principal Investigator
Michael T. Ingram, Sr., M.D., Pei-Hsiu Huang, M.D.
Co-Investigator(s)
David K. Roberts, III, M.D., FACC, Robert Kincade, M.D., FACS